News and Trends 8 Nov 2022 Study shows enhanced drug delivery to the brain …repair are stimulated by biomolecules known as cytokines and growth factors. Unfortunately, delivering adequate concentrations of these molecules to the brain for treating neurological conditions like Alzheimer’s disease is challenging… November 8, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Aug 2018 Modulating the Microbiome Could Boost Vaccine Performance …evident that gut bacteria are linked to a range of different diseases, from Alzheimer’s to inflammatory bowel disease. As a result, biotechs are searching for new treatments that target the… August 9, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jun 2023 How AI can advance research and treatment of CNS disorders …generation of treatments for diseases such as Alzheimer’s, Parkinson’s, and ALS. AI is revolutionizing drug discovery for CNS disorders AI has transformed the drug discovery process for CNS disorders by… June 13, 2023 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jun 2022 NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders …neurodegenerative diseases. Mitochondria make the energy cells need to survive and dysfunction occurs in most neurodegenerative diseases, including Parkinson’s diseases, Alzheimer’s, Huntington’s disease, Friedreich’s ataxia, and amyotrophic lateral sclerosis. Neil Miller,… June 30, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 6 Jul 2017 Watch Europe’s Rising Biotech Startups Battle it out at Refresh …in clinical trials, which could also save a lot of money. The applications could benefit patients suffering from difficult to treat diseases such as Alzheimer’s and cancer. Then came Nova… July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 19 Oct 2016 The ‘First and Only’ Metastatic Lung Cancer Immunotherapy is approved …cancer. And this target is even being explored to treat Alzheimer’s! However, Roche’s main competitor in NSCLC will be MSD’s Keytruda (pembrolizumab), which has shown a similar increase in life… October 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2018 Microsoft Signs its First Microbiome Partnership …our body are key to our health. The microbiome has been linked to conditions such as diabetes, cancer, Alzheimer’s, multiple sclerosis and many more. However, large-scale studies in this field… October 15, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2018 This is Why You Should Avoid Eating too Much Junk Food …inflammasome in Alzheimer’s disease. Interestingly, when mice were returned to their typical diet of cereal for four weeks, inflammation disappeared. However, the changes to the genome of the immune cells… January 15, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2017 British Biotech Founder Receives the Nobel Prize in Chemistry 2017 …a €3Bn deal with Allergan last year to develop drugs for Alzheimer’s and other neurological diseases. Read more about it in our interview with Heptares’ co-founder Fiona Marshall. Images via… October 5, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Feb 2016 Sanofi-Genzyme: Still successful 5 years after the acquisition? …multiple sclerosis (MS) drugs. As we know, the Neurodegenerative disease field (to include MS and Alzheimer’s in particular) has experienced a real revival in the industry. Brandicourt also explained how… February 11, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 19 May 2017 MorphoSys’ First Lanthipeptide Completes Phase I Successfully …of approved drugs and are involved in diseases ranging from cancer to Alzheimer’s. Companies like Confo Therapeutics and Heptares Therapeutics are also going after GPCRs, but none is developing peptide… May 19, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 11 Apr 2023 Is a vaccine for Parkinson’s disease possible? …A Biomarker Platform for Parkinson’s disease – University of Arizona NeuroPREP: Stopping Alzheimer’s & Parkinson’s Disease – University of Helsinki Novel Treatment to Protect against Neurodegenerative Inflammation in Parkinson’s –… April 11, 2023 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email